Results 181 to 190 of about 7,521 (213)

Different models of HBeAg seroconversion predicated by on‐treatment ALT and HBV DNA profiles

Journal of Viral Hepatitis, 2009
Summary.  Pretreatment alanine transaminase (ALT) elevation may be used as a predictor for higher hepatitis B e antigen (HBeAg) seroconversion in chronic hepatitis B patients. However, the role of dynamic changes of on‐treatment ALT for seroconversion is unknown.
Hong, You, Hong, Ma, Tianhui, Liu, Min, Cong, Ping, Wang, Xiaojuan, Ou, Xiaoming, Wang, Jiangbo, Ren, Hongyi, Li, Baoen, Wang, Jidong, Jia   +10 more
openaire   +2 more sources

Mathematical investigation of HBeAg seroconversion

Published ...
Kadelka, Sarah, Ciupe, Stanca M.
openaire   +1 more source

[Epidemiological characteristics of HBeAg reversion in chronic hepatitis B patients with HBeAg seroconversion in Jiangsu province, 2012-2014].

Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi, 2017
Objective: To understand characteristics and influencing factors of reversion of HBeAg in chronic hepatitis B patients with HBeAg sero-conversion, and provide epidemiological evidence for the regular management of chronic hepatitis B patients. Methods: From 2012 to 2014, a cohort study was conducted among the chronic hepatitis B patients with sero ...
L G, Zhu, H, Tian, J, Jiang, C, Song, Y, Zou, J F, Xu, H J, Liu, H, Peng, Z B, Hu, F C, Zhu, H B, Shen, X J, Zhai   +11 more
openaire   +1 more source

[Durability of HBeAg seroconversion in lamivudine treatment of chronic hepatitis B patients].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2007
To investigate the factors which may affect the rate of HBeAg seroconversion and its durability after long-term lamivudine therapy in chronic hepatitis B patients.81 patients were treated in a phase III clinical trial with lamivudine 100 mg daily for up to 5 years.
Mei, Zhu, Bei, Xu, Guang-bi, Yao
openaire   +1 more source

Prevalence of HBeAg and HBsAg seroconversion in patients with chronic hepatitis B.

Sbornik lekarsky, 1995
In 37 patients with chronic hepatitis B in the stage of active viral replication the authors tried to assess the time of seroconversion of HBeAg to anti-HBe and HBsAg to anti-HBs (21 men, 13 women and 3 boys, mean age of adults 44 years). During the 8-years investigation period seroconversion of HBeAg occurred in 19 of 37 patients (51.3%) which is an ...
J, Stránský, A, Chlumská, M, Zichová, R, Helm, L, Mankovecký, J, König   +5 more
openaire   +1 more source

Association of HBeAg decline rate from mid‐pregnancy to delivery with HBeAg seroconversion after delivery in hepatitis B virus‐infected mothers

Journal of Viral Hepatitis
AbstractThere is still controversy about whether to continue antiviral therapy (AVT) after delivery, especially for pregnant women in the immune tolerance (IT) phase. In this study, a retrospective cohort study was conducted to explore the relationship between hepatitis B e antigen (HBeAg) decline rate (%) from mid‐pregnancy to delivery and HBeAg ...
Wenting Zhong, Jie Zheng, Naijuan Yao, Yali Feng, Yage Zhu, Zhe Jiao, Lanzhi Yan, Lei Shi, Yingli He, Tianyan Chen   +9 more
openaire   +2 more sources

Integrative oncology: Addressing the global challenges of cancer prevention and treatment

Ca-A Cancer Journal for Clinicians, 2022
Jun J Mao,, Msce, Lorenzo Cohen, Karen M Mustian   +2 more
exaly  

359 INCREASE RISK OF HBeAg-NEGATIVE CHRONIC HEPATITIS B WITH OLDER AGE AT HBeAg SEROCONVERSION

Journal of Hepatology, 2009
J. Fung, C.L. Lai, D.K.H. Wong, J. Yuen, M.F. Yuen   +4 more
openaire   +1 more source

[Liver histopathological features influencing HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B responding to Peg-IFN treatment].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2014
To investigate the therapeutic efficiency of antiviral treatment with pegylated-interferon (Peg-IFN) for hepatitis B e antigen (HBeAg)-positive chronic hepatitis B (CHB) and to explore whether liver histopathological features or other factors influence the HBeAg seroconversion treatment response.Eighty HBeAg-positive CHB patients with diagnosis ...
Hua-dong, Yan, Fan-rong, Jiang, Cheng-liang, Zhu, Guo-sheng, Gao, Peng-jian, Weng, Ai-rong, Hu, Chang-feng, Xu, Yao-ren, Hu, Ji-fang, Sheng   +8 more
openaire   +1 more source

HBeAg seroconversion and longterm outcome with interferon-??

Inpharma Weekly, 1996
openaire   +1 more source